Newsroom | 12230 results

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Pharma announces patent applications and preclinical data supporting investigational intranasal and pulmonary GLP-1 delivery....

CHICAGO--(BUSINESS WIRE)--The Institute of Food Technologists (IFT), a nonprofit scientific association committed to advancing the science of food and its application across the global food system, will help the global food community restore consumer confidence in two keynote sessions at IFT FIRST Annual Event and Expo, the leading food science and innovation expo being held July 12-15 at McCormick Place in Chicago. “Building Trust: Scientific Consensus and Policy for a Safer Food Future” will...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Hepta, a liquid biopsy company developing blood tests for chronic disease, today announced clinical data showing its blood test more accurately identifies metabolic dysfunction-associated steatohepatitis (MASH) patients eligible for treatment than the three non-invasive tests recommended by current clinical guidelines: FIB-4, ELF, and FibroScan. The 528-patient, multi-cohort study will be presented at the European Association for the Study of the Liver (EAS...

SAN ANTONIO--(BUSINESS WIRE)--WaterOuai!, a new hydration brand founded by Supergoop! creator Holly Thaggard and her son Will Thaggard, launches today with a focus on rethinking one of the most overlooked aspects of daily wellness: the packaging behind the water we drink. Built on a prevention-first philosophy and developed with a materials-first approach, WaterOuai! introduces pure artesian water sourced from the Edwards Aquifer, a 70-million-year-old limestone formation in the Texas Hill Coun...

PALO ALTO, Calif.--(BUSINESS WIRE)--Signos Inc., the company behind the first FDA-cleared, over-the-counter glucose monitoring system for weight management, today announced a $20 million funding round with investment from GV (Google Ventures), Dexcom, and Blue Cross Blue Shield of Alabama. As part of the partnership with Dexcom, Signos will be available for purchase on Stelo.com, Dexcom's direct-to-consumer CGM website, making it easier for people to find and access the Signos system. Signos ha...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced the presentation of new and late-breaking clinical data from the ELIMINATE-B study evaluating PBGENE-HBV at the European Association for the Study of the Liver (EASL) Annual Congress 2026. The late-breaking data, titled ‘First evidence of elimination...

BALTIMORE--(BUSINESS WIRE)--Medifast, Inc. (NYSE: MED) today announced that its Board of Directors has formally appointed Nicholas Johnson as Chief Executive Officer, effective June 1, 2026. Johnson will succeed Dan Chard as CEO, who will continue to serve as Chairman of the Board. The appointment follows the leadership transition plan that the company disclosed in January and reflects the Board’s confidence in Johnson’s leadership and the company’s strategic direction. Chard will remain active...

NEW YORK--(BUSINESS WIRE)--Peloton Interactive, Inc. (NASDAQ: PTON) today announced the appointment of Siddharth (“Sid”) Thacker as the company’s Chief Financial Officer, effective June 22, 2026. Thacker, an accomplished finance leader with a deep foundation as an institutional investor, will oversee Peloton’s global finance organization as well as corporate strategy. Under his leadership, Peloton will maintain its disciplined financial approach while pursuing broader market opportunities acros...

CHICAGO--(BUSINESS WIRE)--CFX, a Chicago-based, family-owned fitness brand with 17 locations, is proud to announce a new partnership with Fitness for Recovery, a nonprofit organization dedicated to helping individuals in recovery from substance use disorder through fitness and offering discounted memberships to any individuals in recovery. The partnership will launch at CFX's Crest Hill location, where Fitness for Recovery participants will have access to CFX clubs, amenities, and group trainin...

カリフォルニア州サンマテオ--(BUSINESS WIRE)--（ビジネスワイヤ） -- Baszucki Groupは本日、精神病に対する臨床的高リスク状態（CHR-P）にある患者を対象に、ケトジェニック食の実施可能性、安全性、有効性を評価するオックスフォード大学の無作為化比較試験を支援するため、117万ポンドの助成金の拠出を発表しました。研究者らは、この栄養療法が患者の精神的・身体的健康を改善できるかを検証します。本プロジェクトは、深刻な精神疾患の治療における代謝療法の可能性を示す研究知見の増加を踏まえたものです。 精神病性障害は当事者に非常に大きな負担をもたらし、平均余命の短縮とも関連しています。精神病は突然発症するわけではなく、通常は早期の軽微な症状が一定期間続いた後に現れます。この段階にある人々はCHR-Pに分類され、予防的介入が可能な重要な時機として位置づけられます。しかし、CHR-Pを検出するための診断ツールは十分に発達している一方で、治療選択肢は限られています。現在、CHR-P患者における本格的な精神病への移行率を低下させる特異的な適応治療は存在しておらず、新たな介入...